These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 1307152)
1. [The efficacy of preparations with antioxidant action in the combined treatment of phlegmons of the maxillofacial area]. Ragimov ChR Stomatologiia (Mosk); 1992; (3-6):35-7. PubMed ID: 1307152 [TBL] [Abstract][Full Text] [Related]
2. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area]. Khamitov FS; Faizov TT; Berim MG Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735 [No Abstract] [Full Text] [Related]
3. [The optimization of the regeneration of a suppurative wound in the maxillofacial area by using lymphogenic therapy]. Shumskiĭ AV; Pozdniĭ AIu; Morozov PV Voen Med Zh; 1999 May; 320(5):28-33. PubMed ID: 10401246 [No Abstract] [Full Text] [Related]
4. [Treatment of patients with phlegmon of the maxillofacial area using a levomecol ointment]. Chernoglazova EM Stomatologiia (Mosk); 1987; 66(5):42-4. PubMed ID: 3480633 [No Abstract] [Full Text] [Related]
5. [Tactivin in the combined treatment of acute inflammatory diseases of the maxillofacial area]. Bazhanov NN; Arion VIa; Sysoeva OP; Krugliakova EP Stomatologiia (Mosk); 1996; 75(2):31-3. PubMed ID: 8754536 [TBL] [Abstract][Full Text] [Related]
6. [New antimicrobial preparations in the overall treatment of suppurative inflammatory processes in the maxillofacial area]. Solomennyĭ SM; Paliĭ GK; Burdeniuk IP Stomatologiia (Mosk); 1979; 58(2):39-41. PubMed ID: 375477 [No Abstract] [Full Text] [Related]
7. [The use of the preparation baliz-2 in inflammatory processes of the maxillofacial area]. Bernadskaia GP; Timofeev AA; Kutsenko TA Stomatologiia (Mosk); 1989; 68(6):10-1. PubMed ID: 2623675 [TBL] [Abstract][Full Text] [Related]
8. [The use of netromycin in suppurative maxillofacial surgery in children]. Roginskiĭ VV; Gerchikov LN; Raĭlian SK; Beliaeva EI; Pavelko GA Stomatologiia (Mosk); 1994; 73(3):68-71. PubMed ID: 7846723 [No Abstract] [Full Text] [Related]
9. [Clinical and experimental bases for using dibasol in inflammatory diseases of the maxillofacial area]. Alekhova TM Stomatologiia (Mosk); 1982; 61(1):15-7. PubMed ID: 6950550 [No Abstract] [Full Text] [Related]
10. [The therapy of inflammatory diseases of the maxillofacial area with the use of imidazole derivatives]. Ushakov RV; Tsarev VN; Dugarov BD; Lopyrev VA Stomatologiia (Mosk); 1992; (3-6):31-4. PubMed ID: 1307150 [TBL] [Abstract][Full Text] [Related]
12. [The antioxidant correction of lipid peroxidation in maxillofacial phlegmons]. Gavriliuk LA; Lungu SE; Shcherbatiuk DI Stomatologiia (Mosk); 1994; 73(2):33-5. PubMed ID: 9612045 [No Abstract] [Full Text] [Related]
13. [Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area]. Drobyshev VIu; Volozhin AI; Agapov VS; Sashkina TI Stomatologiia (Mosk); 1996; 75(4):27-30. PubMed ID: 8992659 [TBL] [Abstract][Full Text] [Related]
14. [Clinical results of perftorane use in comprehensive treatment of patients with odontogenic phlegmons]. Durnovo EA; Furman IV Stomatologiia (Mosk); 2007; 86(4):35-9. PubMed ID: 17828096 [TBL] [Abstract][Full Text] [Related]
15. [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area]. Bazhanov NN; Ganina SS; Pashutin SB; Ragimov ChR Sov Med; 1991; (7):29-31. PubMed ID: 1948337 [TBL] [Abstract][Full Text] [Related]
16. [Neutrophil-macrophage correlations during the healing of suppurative wounds in patients with phlegmons of the maxillofacial area undergoing combined treatment with the use of low-frequency ultrasound]. Mukhsinov ME; Bazhanov NN; Pol'skiĭ VI Stomatologiia (Mosk); 1989; 68(5):45-9. PubMed ID: 2588280 [TBL] [Abstract][Full Text] [Related]
17. [Ways to improve the treatment of patients with phlegmons of the maxillofacial area]. Bazhanov NN; Shcherbatiuk DI Stomatologiia (Mosk); 1992; (1):34-6. PubMed ID: 1440671 [TBL] [Abstract][Full Text] [Related]
18. [Means of decreasing complications in patients with severe inflammatory diseases of the maxillofacial area]. Zakharova GN; Bulkin VA Stomatologiia (Mosk); 1987; 66(3):37-9. PubMed ID: 3475830 [No Abstract] [Full Text] [Related]
19. [The efficacy of using a helium-neon laser, ascorbic acid and methylene blue in the combined treatment of patients with maxillofacial phlegmons]. Bazhanov NN; Ragimov ChR; Kasymov AI Stomatologiia (Mosk); 1990; (5):35-7. PubMed ID: 2281486 [TBL] [Abstract][Full Text] [Related]
20. [The intestinal microflora of patients with inflammatory diseases of the maxillofacial area]. Bevz NI; Budanova EV; Pashkov EP; Ter-Asaturov GP; Goncharova GI Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):22-4. PubMed ID: 7992527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]